109322-14-7 Usage
Type of compound
Hydrazinecarbothioamide derivative
Potential activities
Anti-cancer and anti-tumor
Therapeutic effects
Inhibiting the growth of cancer cells and reducing tumor size
Mechanism of action
Targeting specific pathways and molecules involved in cancer cell proliferation and survival
Current status
Under investigation for potential use in cancer treatment
Check Digit Verification of cas no
The CAS Registry Mumber 109322-14-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,9,3,2 and 2 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 109322-14:
(8*1)+(7*0)+(6*9)+(5*3)+(4*2)+(3*2)+(2*1)+(1*4)=97
97 % 10 = 7
So 109322-14-7 is a valid CAS Registry Number.
109322-14-7Relevant articles and documents
Synthesis of 2/9-Substituted Indophenazin-6-acetic Acid &α-Aryl/methylbenzylidenehydrazides, 4-Aryl-1-(indophenazin-6-methylcarbonyl)-3-thiosemicarbazides and 6-(4-Aryl-5-mercapto-4H-1,2,4-triazol-3-ylmethyl)indophenazines as CNS Active and Antiinflammato
Mohan, Rajiv Ravindra,Agarwal, Rajesh,Misra, V. S.
, p. 1234 - 1237 (2007/10/02)
2/9-Substituted indophenazine-6-acetic acid α-aryl/methylbenzylidenehydrazides (IVa-l) and 4-aryl-1-(2/9-substituted indophenazin-6-methylcarbonyl)-3-thiosemicarbazides (Va-j) have been synthesised by condensing 2/9-substituted indophenazin-6-acetic acid